Renal Cell Carcinoma

Cryoablation Offers Long-Term RCC Control

Cryoablation Offers Long-Term RCC Control

By

The 5-year disease-free and cancer-specific survival rates were 94.7% and 100%, respectively.

Radiofrequency Ablation May Be a Valid Approach for RCC

Radiofrequency Ablation May Be a Valid Approach for RCC

By

Study shows it can provide durable oncologic control with a low risk of tumor recurrence.

Renal Tumor Ablation Via the Liver Is Safe, Effective

Renal Tumor Ablation Via the Liver Is Safe, Effective

By

In a small study, researchers show that ultrasound-guided transhepatic radiofrequency ablation is technically feasible.

CDC: Cancer Prevention Services Below Target Goals

CDC: Cancer Prevention Services Below Target Goals

Increasing health insurance coverage and access to usual source of care necessary to meet targets.

Personalized Medicine in 2014

Personalized Medicine in 2014

By

The term "personalized medicine" remains an overused promise to apply specific treatment plans.

Perioperative Blood Transfusions Hike RCC Patient Mortality

Perioperative Blood Transfusions Hike RCC Patient Mortality

By

Researchers find a 23% increased risk of death among patients who received a transfusion during surgery or post-operative hospitalization.

Kidney Cancer Rarely Recurs After MIPN

Kidney Cancer Rarely Recurs After MIPN

By

The estimated recurrence rate at 10 years was 88.3%, data show.

Expressive Writing Benefits Kidney Cancer Patients

Expressive Writing Benefits Kidney Cancer Patients

Benefits in cancer-linked symptoms mediated by lower Impact of Event Scale one month after intervention.

Diabetes Ups Kidney Cancer Patient Death Risk

Diabetes Ups Kidney Cancer Patient Death Risk

By

Diabetes also found to increase cancer-specific mortality in patients with clear cell renal cell carcinoma.

Kidney Cancer Survival Improved by BP Drugs

Kidney Cancer Survival Improved by BP Drugs

By

ACE inhibitors and angiotensin receptor blockers were shown to prolong median overall survival by nine months.

Kidney Cancer Cryoablation Highly Effective, Safe

Kidney Cancer Cryoablation Highly Effective, Safe

By

The five-year cancer-specific and overall survival rates were 100% and 97.8%, respectively.

Kidney Cancer Patients Should Stop Smoking When Starting Sunitinib

By

Active smoking shortens progression-free and overall survival, study finds.

Kidney Cancer Prognosis Linked to Blood Type

Kidney Cancer Prognosis Linked to Blood Type

By

Patients with blood group O have a lower risk of lymph node metastases but a higher risk of bilateral disease.

New Ablative Techniques in Urologic Oncology

Innovative approaches offer the potential for effective treatments to limited target 
areas with improved side effect profiles.

Papillary Renal Cell Cancer Linked to Renal Cysts

By

Patients with this malignancy had a 73% prevalence of simple renal cysts.

Early RCC Recurrence Predicts Worse Cancer-Specific Survival

By

Recurrence that occurs more than 48 months after surgery is no longer significantly associated with reduced survival from renal cell carcinoma.

Adjuvant Radiotherapy May Benefit High-Risk RCC Patients

By

Researchers observe a high rate of local disease control with increased progression-free survival.

Drug May Offer Edge for Metastatic Kidney Cancer

By

In a head-to-head trial, patients had similar progression-free survival with pazopanib and sunitinib, but experienced fewer adverse effects.

RCC Prevalence 'Surprisingly High' in ADPKD Patients

By

Renal cancers were found in 5% of patients with autosomal dominant polycystic kidney disease.

Metastatic RCC Outcomes Worse with Bone Involvement

By

Bone metastases shorten progression-free and overall survival, study finds.

Statins Improve Kidney Cancer Surgery Outcomes

By

Study demonstrates improved disease-specific and overall survival.

Data Support Robot-Assisted Partial Nephrectomy for Kidney Cancer

By

Cancer-specific and the cancer-free survival rates were 99% at three and five years.

CKD Risk Higher with Radical Nephrectomy

By

Risk is threefold greater when compared with partial nephrectomy.

Percutaneous Cryoablation An Option for Renal Tumors

By

It is associated with a high technical success rate and a low rate of complications; local recurrence rare.

Renal Cryoablation Outcomes Durable

By

After a median follow-up of 36 months, 98% of patients had no recurrence of small renal tumors.

High BMI, Visceral Obesity May Benefit Kidney Cancer Patients

By

For patients with metastatic disease receiving systemic treatment, a high BMI was found to improve overall survival.

RCC Incidence Higher Among Dialysis Patients

By

Biopsy-proven renal cell carcinoma developed in 35 (0.5%) of 6,827 ESRD patients.

Women Less Likely to Die from Kidney Cancer

By

The survival advantage over men is greatest among women younger than 42 years.

Dual CKD Risk Factors Prompt Greater Nephron-Sparing Surgery Use

By

Kidney cancer patients with both hypertension and diabetes are twice as likely to undergo nephron-sparing surgery as those with neither condition.

Partial Nephrectomy Prolongs Survival in Younger Patients

By

The 10-year overall survival rate was 94% for partial nephrectomy compared with 89.7% for radical nephrectomy in patients aged 20-44.

Sign Up for Free e-newsletters